Eleanor Brown

Aug 14, 2024 | biorxiv.org | Eleanor Brown |Mai-Anh T Vu |Safa Bouabid |Yihan Zi

AbstractGoal-directed navigation requires animals to continuously evaluate their current direction and speed of travel relative to landmarks to discern whether they are approaching or deviating from their goal. Striatal dopamine and acetylcholine are powerful modulators of goal-directed behavior, but it is unclear whether and how neuromodulator dynamics at landmarks incorporate relative motion for effective behavioral guidance.

Mar 8, 2024 | invesbrain.com | Kathleen Abadie |Ph.D. candidate |Eleanor Brown

Juan Gaertner/Science Photo Library via Getty Images How does your immune system decide between fighting invading pathogens now or preparing to fight them in the future? Turns out, it can change its mind. Every person has 10 million to 100 million unique T cells that have a critical job in the immune system: patrolling the body for invading pathogens or cancerous cells to eliminate.

Mar 8, 2024 | invesbrain.com | Eleanor Brown |Andrew Dunn |Brooklee Han

After some halting starts, false dawns and fragile rallies, the biotech market may finally be back. No, really. In the last several months, several important signals have added up to what feels like a rally, with more depth and certainty than some of the short-lived upticks during the doldrums of 2022 and 2023, when only the industry's most optimistic souls were willing to call it a comeback.

Mar 8, 2024 | invesbrain.com | Eleanor Brown |Andrew Dunn |Brooklee Han

After some halting starts, false dawns and fragile rallies, the biotech market may finally be back. No, really. In the last several months, several important signals have added up to what feels like a rally, with more depth and certainty than some of the short-lived upticks during the doldrums of 2022 and 2023, when only the industry's most optimistic souls were willing to call it a comeback.

Mar 8, 2024 | invesbrain.com | Lance Roberts |Eleanor Brown

In September 2021, I discussed how the markets had set its sights on the S&P 500 index hitting 5000. To wit. "Yes, the rally off the COVID-19 bottom in March 2020 has been extraordinary, but we think there are further gains ahead. Solid economic and corporate profit growth, in conjunction with a still-accommodative Fed, means that the environment for stocks remains favorable.